Exhibit 99.1

 

Joint Filing Agreement

 

The undersigned hereby agree that the Statement on Schedule 13G dated January 6, 2025 with respect to the Common Stock, $0.0001 par value per share, of RAPT Therapeutics, Inc., a Delaware corporation, and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.

 

BIOTECHNOLOGY VALUE FUND L P
 
By:

/s/ Mark N. Lampert

  
  Mark N. Lampert, Authorized Signatory
Date: 01/06/2025

 

BVF I GP LLC
 
By:

/s/ Mark N. Lampert

  
  Mark N. Lampert, Authorized Signatory
Date: 01/06/2025

 

BIOTECHNOLOGY VALUE FUND II LP
 
By:

/s/ Mark N. Lampert

  
  Mark N. Lampert, Authorized Signatory
Date: 01/06/2025

 

BVF II GP LLC
 
By:

/s/ Mark N. Lampert

  
  Mark N. Lampert, Authorized Signatory
Date: 01/06/2025

 

Biotechnology Value Trading Fund OS LP
 
By:

/s/ Mark N. Lampert

  
  Mark N. Lampert, Authorized Signatory
Date: 01/06/2025

 

BVF Partners OS Ltd.
 
By:

/s/ Mark N. Lampert

  
  Mark N. Lampert, Authorized Signatory
Date: 01/06/2025

 

BVF GP HOLDINGS LLC
 
By:

/s/ Mark N. Lampert

  
  Mark N. Lampert, Authorized Signatory
Date: 01/06/2025

 

BVF PARTNERS L P/IL
 
By:

/s/ Mark N. Lampert

  
  Mark N. Lampert, Authorized Signatory
Date: 01/06/2025

 

BVF INC/IL
 
By:

/s/ Mark N. Lampert

  
  Mark N. Lampert, Authorized Signatory
Date: 01/06/2025

 

LAMPERT MARK N
 
By:

/s/ Mark N. Lampert

  
  Mark N. Lampert
Date: 01/06/2025

 

RAPT Therapeutics (NASDAQ:RAPT)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more RAPT Therapeutics Charts.
RAPT Therapeutics (NASDAQ:RAPT)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more RAPT Therapeutics Charts.